semaglutide glucose study Two-year effects of in adults with overweight or obesity: the STEP 5 trial Semaglutide weight loss results linked

Accordingly, excess DPP-4, derived from adipocytes and/or hepatocytes, may act as a local mediator of inflammation and adipose/hepatic tissue insulin resistance, thereby forming one link between obesity and the pathogenesis of T2DM and metabolic disease (Figure 3)

The improvement effect of semaglutide on obese mice is partially driven by changes in serum metabolism and gut microbiota, as confirmed by fecal transplant experiments in this study

The following graphic depicts common symptoms and the organ systems affected

While long-term use of semaglutide appears to be safe for many people, monitoring and regular check-ups with a doctor are essential

10.1186/s12882-019-1341-y 29

Ketones and the heart: metabolic principles and therapeutic implications